Frank Torti - 19 Feb 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Reporting relationship: President and Vant Chair
Issuer ticker: ROIV
Reported as of: 19 Feb 2026
Net transaction value: -$70,489,460
SEC form: 4
Accepted by SEC: 23 Feb 2026, 20:40:19 UTC
Prior SEC filing: 29 Dec 2025
Next SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Jo Chen, as Attorney-in-Fact for Frank Torti

Key filing fact

Frank Torti filed Form 4 for Roivant Sciences Ltd. (ROIV) on 23 Feb 2026.

Key facts

This page summarizes Frank Torti's Form 4 filing for Roivant Sciences Ltd. (ROIV).
9 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 23 Feb 2026, 20:40.

Change

Previous filing in this sequence was filed on 29 Dec 2025.
Current net transaction value: -$70,489,460.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001647805 Primary reporting owner

Torti Frank

Relationship: President and Vant Chair
Address: C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Frank Torti
Signature date: 23 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Options Exercise

Transaction value: $5,390,000
Shares: +1,400,000
Change %: +10%
Price: $3.85
Shares after: 15,136,547
Date: 19 Feb 2026
Ownership: Direct

ROIV transaction

Common Shares

Sale

Transaction value: $38,388,000
Shares: -1,400,000
Change %: -9.2%
Price: $27.42
Shares after: 13,736,547
Date: 19 Feb 2026
Ownership: Direct
Footnotes: F1, F2

ROIV transaction

Common Shares

Options Exercise

Transaction value: $3,898,548
Shares: +1,012,610
Change %: +7.4%
Price: $3.85
Shares after: 14,749,157
Date: 20 Feb 2026
Ownership: Direct

ROIV transaction

Common Shares

Sale

Transaction value: $27,492,362
Shares: -1,012,610
Change %: -6.9%
Price: $27.15
Shares after: 13,736,547
Date: 20 Feb 2026
Ownership: Direct
Footnotes: F1, F3

ROIV transaction

Common Shares

Options Exercise

Transaction value: $2,261,452
Shares: +587,390
Change %: +4.3%
Price: $3.85
Shares after: 14,323,937
Date: 23 Feb 2026
Ownership: Direct

ROIV transaction

Common Shares

Sale

Transaction value: $16,159,099
Shares: -587,390
Change %: -4.1%
Price: $27.51
Shares after: 13,736,547
Date: 23 Feb 2026
Ownership: Direct
Footnotes: F1, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ROIV transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -1,400,000
Change %: -23%
Price: $0.000000
Shares after: 4,626,184
Date: 19 Feb 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 1,400,000
Exercise price: $3.85
Footnotes: F5

ROIV transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -1,012,610
Change %: -22%
Price: $0.000000
Shares after: 3,613,574
Date: 20 Feb 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 1,012,610
Exercise price: $3.85
Footnotes: F5

ROIV transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -587,390
Change %: -16%
Price: $0.000000
Shares after: 3,026,184
Date: 23 Feb 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 587,390
Exercise price: $3.85
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Footnote F2

These Common Shares were sold in multiple transactions at prices ranging from $27.00 to $27.64, inclusive.

Footnote F3

These Common Shares were sold in multiple transactions at prices ranging from $26.70 to $27.45, inclusive.

Footnote F4

These Common Shares were sold in multiple transactions at prices ranging from $27.14 to $27.80, inclusive.

Footnote F5

Reflects an award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date (except as otherwise provided in the award documentation).

SEC remarks

The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's shares subject to the trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act entered into by the reporting person on November 20, 2025 which provided for the potential sale of up to 3,000,000 common shares held by the reporting person between February 19, 2026 and June 30, 2026.